These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8700375)

  • 1. Successful trial of steroids in two haemodialysis patients with inflammatory disease and anaemia unresponsive to recombinant erythropoietin.
    Tzanakis I; Markidou F; Tzimis L; Kartsonakis V; Mamali V; Xini K; Kallivretakis N
    Nephrol Dial Transplant; 1996 Feb; 11(2):400-1. PubMed ID: 8700375
    [No Abstract]   [Full Text] [Related]  

  • 2. rHuEpo-resistant anaemia in haemodialysis patients.
    Ozono Y; Harada T; Taura K; Kawatomi M; Hara K
    Nephrol Dial Transplant; 1994; 9(7):872-4. PubMed ID: 7970133
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
    Raiola P; Manzo M; Saggese A; Tomasino G; Cicchella T; Rambaldi M; Pisano M; Lizza B; Perna AF
    Nephrol Dial Transplant; 1995; 10 Suppl 6():48-50. PubMed ID: 8524495
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 5. Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.
    Muirhead N; Hodsman AB
    Nephrol Dial Transplant; 1990; 5(3):232-4. PubMed ID: 2113653
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to recombinant human erythropoietin in a hemodialysis patient with lupus reactivation.
    Romero R; Novoa D; Perez-Freiria A; Arcocha V; Alonso R; Arza D; Lens XM; Sanchez-Guisande D
    Nephron; 1995; 69(3):343-4. PubMed ID: 7753275
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaemia management protocols in the care of haemodialysis patients: examining patient outcomes.
    Saunders S; MacLeod ML; Salyers V; MacMillan PD; Ogborn MR
    J Clin Nurs; 2013 Aug; 22(15-16):2206-15. PubMed ID: 23336392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 9. An unusual etiology of erythropoietin resistance: hyperthyroidism.
    Kaynar K; Ozkan G; Erem C; Gul S; Yilmaz M; Sonmez B; Ozdemir F; Ulusoy S
    Ren Fail; 2007; 29(6):759-61. PubMed ID: 17763175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin.
    Castelli G; Famularo A; Semino C; Machi AM; Ceci A; Cannella G; Melioli G
    Pharmacol Res; 2000 Mar; 41(3):313-8. PubMed ID: 10675283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.
    Zehnder C; Glück Z; Descoeudres C; Uehlinger DE; Blumberg A
    Nephrol Dial Transplant; 1988; 3(5):657-60. PubMed ID: 3146724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
    Winearls CG
    Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin and haemodialyser re-use.
    Dos Santos JP; Prata MM; Sousa FT; Barbas JV
    Nephron; 1990; 56(4):447-8. PubMed ID: 2080010
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
    BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.